SMTI
Price
$21.92
Change
+$0.85 (+4.03%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
188.27M
118 days until earnings call
Intraday BUY SELL Signals
STXS
Price
$2.44
Change
+$0.11 (+4.72%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
217.45M
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SMTI vs STXS

Header iconSMTI vs STXS Comparison
Open Charts SMTI vs STXSBanner chart's image
Sanara MedTech
Price$21.92
Change+$0.85 (+4.03%)
Volume$400
Capitalization188.27M
Stereotaxis
Price$2.44
Change+$0.11 (+4.72%)
Volume$1.46K
Capitalization217.45M
SMTI vs STXS Comparison Chart in %
SMTI
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SMTI vs. STXS commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMTI is a StrongBuy and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (SMTI: $21.07 vs. STXS: $2.33)
Brand notoriety: SMTI and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SMTI: 126% vs. STXS: 113%
Market capitalization -- SMTI: $188.27M vs. STXS: $217.45M
SMTI [@Pharmaceuticals: Other] is valued at $188.27M. STXS’s [@Pharmaceuticals: Other] market capitalization is $217.45M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.96B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMTI’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • SMTI’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMTI’s TA Score shows that 6 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • SMTI’s TA Score: 6 bullish, 3 bearish.
  • STXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SMTI is a better buy in the short-term than STXS.

Price Growth

SMTI (@Pharmaceuticals: Other) experienced а +1.49% price change this week, while STXS (@Pharmaceuticals: Other) price change was -4.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.46%. For the same industry, the average monthly price growth was +7.98%, and the average quarterly price growth was +3.65%.

Reported Earning Dates

SMTI is expected to report earnings on Apr 01, 2026.

STXS is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.46% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($217M) has a higher market cap than SMTI($188M). STXS YTD gains are higher at: 2.193 vs. SMTI (-36.536). SMTI has higher annual earnings (EBITDA): 147K vs. STXS (-22.41M). SMTI has more cash in the bank: 17M vs. STXS (6.97M). STXS has less debt than SMTI: STXS (5.73M) vs SMTI (45.5M). SMTI has higher revenues than STXS: SMTI (97.2M) vs STXS (31.8M).
SMTISTXSSMTI / STXS
Capitalization188M217M87%
EBITDA147K-22.41M-1%
Gain YTD-36.5362.193-1,666%
P/E RatioN/AN/A-
Revenue97.2M31.8M306%
Total Cash17M6.97M244%
Total Debt45.5M5.73M794%
FUNDAMENTALS RATINGS
SMTI vs STXS: Fundamental Ratings
SMTI
STXS
OUTLOOK RATING
1..100
511
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
9264
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SMTI's Valuation (89) in the null industry is in the same range as STXS (99) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

SMTI's Profit vs Risk Rating (100) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

SMTI's SMR Rating (96) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (64) in the Medical Specialties industry is in the same range as SMTI (92) in the null industry. This means that STXS’s stock grew similarly to SMTI’s over the last 12 months.

STXS's P/E Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for SMTI (100) in the null industry. This means that STXS’s stock grew somewhat faster than SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMTISTXS
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
81%
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
SMTI
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VULNF3.740.21
+6.09%
Vulcan Energy Resources Ltd.
BRDCF47.50N/A
N/A
Bridgestone Corp.
MAGE0.22N/A
N/A
Magellan Copper and Gold Corp.
RTMAF1.48N/A
N/A
Reitmans (Canada) Limited
NPEHF20.31N/A
N/A
NIPPON EXPRESS HLDGS INC.

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
+4.31%
A - SMTI
47%
Loosely correlated
+0.30%
NTRA - SMTI
45%
Loosely correlated
+0.66%
MTD - SMTI
44%
Loosely correlated
-0.85%
TWST - SMTI
44%
Loosely correlated
+4.95%
IQV - SMTI
44%
Loosely correlated
+0.71%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+3.56%
SMTI - STXS
41%
Loosely correlated
+4.31%
NVST - STXS
37%
Loosely correlated
+1.34%
TWST - STXS
36%
Loosely correlated
+4.95%
PLSE - STXS
36%
Loosely correlated
+3.85%
CERS - STXS
35%
Loosely correlated
+6.42%
More